Personalized Predictive Care. Anywhere.

Powered by artificial intelligence and machine learning, Biofourmis enables the delivery of care to patients in nearly any location, providing unique insights into each patient’s condition.

Biofourmis Care™

Personalize care virtually anywhere, with customized solutions to help clinicians provide care to patients with acute, post-acute, and chronic conditions.

Establish personalized patient baseline and provide notifications as patient conditions change
Tailor care based on context-rich patient insight and specific conditions
Intervene early to get ahead of deterioration and decompensation
Clinicians can simultaneously deliver patient care in a healthcare facility and to virtual beds
Customized deployment with health navigators, clinicians, technical support, and logistics management available 24/7

Biofourmis Therapeutics™

Biofourmis is advancing drug development, clinical research, and Software as a Medical Device (SaMD) through the use of the latest artificial intelligence and machine learning technology across a spectrum of therapeutic areas.

Intelligent care, anywhere, begins with Biofourmis

One Partner for Your Virtual Care Needs

Our customized, end-to-end solutions with our FDA-cleared analytics platform enable world-class care to patients and advanced insight to clinicians.

Continuous, Real-Time Monitoring

Patient App Designed to Optimize Engagement and Adherence

FDA-cleared Analytics Platform

Actionable Notifications for Clinicians

Enterprise-level Scale and Integration

One Partner for Your Virtual Care Needs

Our customized, end-to-end solutions with our FDA-cleared analytics platform enable world-class care to patients and advanced insight to clinicians.

Continuous, Real-time Monitoring

Patient App Designed to Optimize Engagement and Adherence

FDA-cleared Analytics Platform

Actionable Notification for Clinicians

Enterprise-level Scale and Integration

Welcome to the Next Level of Care

Delivery of care from anywhere, powered by the Biovitals analytics engine. The Biovitals FDA-cleared software utilizes AI and machine-learning to deliver meaningful notifications and unique insights to care teams.

Utilizing Clinical Evidence and Science as our Guide

Around the world and across multiple collaborations and studies, Biofourmis is helping clinical teams see patients like never before.

BioVitalsHF Treatment Algorithms
Circulation, AHA Journal

This RCT demonstrated that an algorithm-driven, navigator-administered medication optimized program enhanced implementation of GDMT compared with usual care in patients with HFrEF. The data supports remote titration using our Biovitals Treatment algorithms for personalized, sequential, stepped titration of guideline-directed heart failure medication therapies.

Remote Monitoring with Biosensors and AI
Annals of Internal Medicine

This RCT demonstrated substitutive hospital-level care in a patient’s home may reduce cost, health care use and readmissions, while improving the patient experience. Patients were monitored using a wearable biosensor patch and machine-based algorithms, which produced alarms for review by nurses and physicians.

BioVitals A Personalized Physiology Analytics
IEEE Explore

This study demonstrated the ability of our FDA-cleared BioVitals Analytics Engine to detect subtle physiology changes precursor to decompensation in patients with chronic conditions. The data validates the use of our device- and disease-agnostic platform for continuous physiology monitoring.

RhythmAnalytics – Deep Learning for Arrhythmia Detection arXive.org – Cornell University

This study demonstrated the capability of our FDA-cleared RhythmAnalytics platform to detect >15 types of cardiac arrhythmias using continuous ECG recordings. The overall performance of RhythmAnalytics outperformed a panel of cardiologists and other industry-leading detection models.

Awards

FierceHealthcare’s Fierce 15 Award in 2020

Since its founding in 2015, digital therapeutics and remote monitoring startup Biofourmis has been trying to figure out how to move healthcare beyond the pill.

Forbes AI 50 2020: America’s Most Promising Artificial Intelligence Companies

Forbes partnered with venture firms Sequoia Capital and Meritech Capital to create our second annual AI 50, a list of private, U.S.-based companies that are using artificial intelligence in meaningful business-oriented ways.

Annual ranking of the 150 most promising digital health startups in the world.

In 2019, digital health companies from 18 countries spanning 17 overarching categories were selected for the first-ever annual CB Insights Digital Health 150.

Trusted by Leading Health Systems, Providers, Pharmaceutical Companies, and More

Biofourmis in The News

Let’s get you up to speed.

Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”

Biofourmis nets FDA breakthrough label for digital heart failure treatment assistant

Biofourmis appoints chief commercial officer

Softbank-Backed Health AI Startup Moves Into Clinical Care With Key Amazon Hire

The Healthcare Revolution at Home

Expect more remote monitoring, adoption of predictive analytics in 2021

Brigham and Women’s and Biofourmis codevelop home hospital technology

Brigham and Women’s, Biofourmis launch hospital-at-home solution nationwide

Start-up that uses wearables to track whether drugs are effective gets $100 million infusion led by SoftBank

SoftBank Leads $100 Million Investment In AI And Digital Therapeutics Startup Biofourmis

Biofourmis, Chugai to develop wearable for digitally measuring endometriosis pain

Chugai, Biofourmis partner on DTx for pain monitoring

Remote Monitoring’s Role in Treating COVID

MDLive appoints new CMO, another C-suite update for Biofourmis and more digital health hires

Startup Biofourmis moves into oncology with Gaido Health acquisition

Can AI predict a coronavirus infection before doctors even do a test?

Here’s what Business Insider Intelligence analysts think will be the biggest business impacts of the coronavirus pandemic

Biofourmis’ AI-fueled remote monitoring tech provides insights in fight against COVID-19

Biofourmis Teams Up With University of Hong Kong to Fight Coronavirus

Startup Biofourmis Using AI-Based System to Battle Coronavirus

Biofourmis names COO, CTO

Biofourmis teams up with Novartis to commercialize a digital therapeutics platform for heart failure patients

Massachusetts-based Biofourmis to acquire Zurich wearable company

Biofourmis Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

Yale, Mayo Clinic tap Biofourmis’ sensors and the new Apple Watch to study digital endpoints for heart disease

FDA, Yale, Mayo Clinic Join Forces to Study Cardiac mHealth Data

25 Machine Learning Startups To Watch In 2019

Medtech firm Biofourmis to move HQ to Boston, triple headcount

Biofourmis raises $35M to develop smarter treatments for chronic diseases

What Our Customers Are Saying

“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital therapeutics, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology.”

"The Everion^® biosensor has become part of my daily habit. I wear it and forget about it and I know a care team is always there to make sure I am safe."

"The goal of this program is to leverage Biovitals^® to remotely monitor patients and identify COVID-19 related physiological biomarkers that indicate deterioration in patients."

Personalized Predictive Care. Anywhere.

Powered by artificial intelligence and machine learning, Biofourmis enables the delivery of care to patients in nearly any location, providing unique insights into each patient’s condition.

Biofourmis Care™

Biofourmis Therapeutics™

Intelligent care, anywhere, begins with Biofourmis

One Partner for Your Virtual Care Needs

Continuous, Real-Time Monitoring

Patient App Designed to Optimize Engagement and Adherence

FDA-cleared Analytics Platform

Actionable Notifications for Clinicians

Enterprise-level Scale and Integration

One Partner for Your Virtual Care Needs

Continuous, Real-time Monitoring

Patient App Designed to Optimize Engagement and Adherence

FDA-cleared Analytics Platform

Actionable Notification for Clinicians

Enterprise-level Scale and Integration

Welcome to the Next Level of Care

Utilizing Clinical Evidence and Science as our Guide

Awards

FierceHealthcare’s Fierce 15 Award in 2020

Forbes AI 50 2020: America’s Most Promising Artificial Intelligence Companies

Annual ranking of the 150 most promising digital health startups in the world.

Trusted by Leading Health Systems, Providers, Pharmaceutical Companies, and More

Biofourmis in The News

Let’s get you up to speed.

What Our Customers Are Saying

Start Delivering Powerful, Predictive, Virtual Care Today